About

Company description

By applying its unique combination of bio-transformations and organic synthesis, Kaneka is manufacturing advanced intermediates for 40 years for the pharmaceutical industry. Kaneka is a research driven manufacturer supplying valuable chiral synthons produced by innovative and cost-effective processes. Kaneka's intensive R&D activities make it possible to support its customers worldwide from laboratory over pilot to full GMP manufacturing scale.Kaneka is the pioneer in natural CoQ10 (Ubidecarenone) and is the only manufacturer offering also the biologically-active form (Ubiquinol).Kaneka Eurogentec offers contract GMP biologics manufacturing (proteins, plasmids, and conjugates, through microbial fermentation via its FDA-approved production site in Belgium.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Chiral Intermediates |APIs |Custom Manufacturing More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 5F53 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 101C20 See our Exhibitor Profile   See full Exhibitor List

News about Kaneka Eurogentec S.A.

Kaneka officially starts continuous manufacturing in GMP condition

20 Aug 2018

Kaneka officially starts continuous manufacturing in GMP condition

 Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) installed continuous manufacturing equipment to be applied to small molecule pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko Yamada) and have started commercial production in GMP*1 condition June 2018.

Read more
Kaneka Eurogentec S.A.

Contact information

Address

Telephone

Website

View all contact information